These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29338462)

  • 41. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The coronary sinus reducer: clinical evidence and technical aspects.
    Giannini F; Aurelio A; Jabbour RJ; Ferri L; Colombo A; Latib A
    Expert Rev Cardiovasc Ther; 2017 Jan; 15(1):47-58. PubMed ID: 27935738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris.
    Gosai JN; Charalampidis P; Nikolaidou T; Parviz Y; Morris PD; Channer KS; Jones TH; Grech ED
    Andrology; 2016 May; 4(3):486-91. PubMed ID: 27027684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
    Sakamoto T; Ogawa H; Nakao K; Hokimoto S; Tsujita K; Koide S; Yamamoto N; Shimomura H; Matsumura T; Oshima S; Kikuta K; Oka H; Kimura K; Matsui K;
    J Cardiol; 2016 Apr; 67(4):371-7. PubMed ID: 26254019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Annual cost of stable coronary artery disease in France: A modeling study.
    Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
    Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials.
    Kok MM; van der Heijden LC; Sen H; Danse PW; Löwik MM; Anthonio RL; Louwerenburg JH; de Man FH; Linssen GC; IJzerman MJ; Doggen CJ; Maas AH; Mehran R; von Birgelen C
    JACC Cardiovasc Interv; 2016 Mar; 9(6):553-61. PubMed ID: 26947384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention.
    Wakabayashi Y; Wada H; Sakakura K; Yamamoto K; Mitsuhashi T; Ako J; Momomura S
    J Cardiol; 2015 Oct; 66(4):341-6. PubMed ID: 25614292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PCI for stable angina: A missed opportunity for shared decision-making.
    Rothberg MB
    Cleve Clin J Med; 2018 Feb; 85(2):105-121. PubMed ID: 29425088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous Coronary Intervention of Coronary Chronic Total Occlusions Improves Peak Oxygen Uptake During Cardiopulmonary Exercise Testing.
    Abdullah SM; Hastings JL; Amsavelu S; Garcia-Morales F; Hendrix F; Karatasakis A; Danek BA; Karacsonyi J; Rangan BV; Roesle M; Khalili H; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Mar; 29(3):83-91. PubMed ID: 28255103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader F; Pathimagaraj RH; Nijjer S; Sen S; Petraco R; Clesham G; Johnson T; Harrell FE; Kellman P; Francis D; Shun-Shin M; Howard J; Cole GD; Al-Lamee R
    EuroIntervention; 2024 Feb; 20(3):e216-e223. PubMed ID: 38214677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishing the cost-effectiveness of percutaneous coronary intervention for chronic total occlusion in stable angina: a decision-analytic model.
    Gada H; Whitlow PL; Marwick TH
    Heart; 2012 Dec; 98(24):1790-7. PubMed ID: 23038791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low yield of stress imaging in a population-based study of asymptomatic patients after percutaneous coronary intervention.
    Peterson T; Askew JW; Bell M; Crusan D; Hodge D; Gibbons RJ
    Circ Cardiovasc Imaging; 2014 May; 7(3):438-45. PubMed ID: 24687040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).
    Valgimigli M; Tricoci P; Huang Z; Aylward PE; Armstrong PW; Van de Werf F; Leonardi S; White HD; Widimsky P; Harrington RA; Cequier A; Chen E; Lokhnygina Y; Wallentin L; Strony J; Mahaffey KW; Moliterno DJ
    Am J Cardiol; 2014 Sep; 114(5):665-73. PubMed ID: 25129064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.
    Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Arnold SV; Kleiman NS; Spertus JA;
    Cardiovasc Revasc Med; 2017; 18(3):169-176. PubMed ID: 28041858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).
    Huisman J; van der Heijden LC; Kok MM; Danse PW; Jessurun GA; Stoel MG; van Houwelingen KG; Löwik MM; Hautvast RW; IJzerman MJ; Doggen CJ; von Birgelen C
    Am Heart J; 2016 May; 175():121-9. PubMed ID: 27179731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.